3,688
edits
No edit summary |
No edit summary |
||
Line 27: | Line 27: | ||
[https://pubmed.ncbi.nlm.nih.gov/29533517/ Clinical use of plasma lactate concentration. Part 2: Prognostic and diagnostic utility and the clinical management of hyperlactatemia] | [https://pubmed.ncbi.nlm.nih.gov/29533517/ Clinical use of plasma lactate concentration. Part 2: Prognostic and diagnostic utility and the clinical management of hyperlactatemia] | ||
https://www.sciencedirect.com/science/article/abs/pii/S0002962923011813 | https://www.sciencedirect.com/science/article/abs/pii/S0002962923011813 | ||
Mietzsch U, Wood TR, Wu T-W, et al. Early Glycemic State and Outcomes of Neonates With Hypoxic-Ischemic Encephalopathy. Pediatrics. 2023;152(4)doi:10.1542/peds.2022-060965 | |||
Chavez-Valdez R, Aziz K, Burton VJ, Northington FJ. Worse Outcomes From HIE Treatment Associated With Extreme Glycemic States. Pediatrics. 2023;152(4)doi:10.1542/peds.2023-062521 | |||
Thornton PS, Stanley CA, De Leon DD, et al. Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children. The Journal of pediatrics. Aug 2015;167(2):238-45. doi:10.1016/j.jpeds.2015.03.057 | |||
Of historical interest… | Of historical interest… | ||
Holliday, M.A. and W.E. Segar, The maintenance need for water in parenteral fluid therapy. Pediatrics, 1957. 19(5): p. 823-32. | Holliday, M.A. and W.E. Segar, The maintenance need for water in parenteral fluid therapy. Pediatrics, 1957. 19(5): p. 823-32. |